Akero Therapeutics Inc
AKRO
Market Cap$3B
Close$
$5.06
86.9% downside
Current Fair Value
86.9% downsideOvervalued by 86.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.00 Billion |
|---|---|
| Enterprise Value | $2.69 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.75 |
| Beta | -0.18 |
| Outstanding Shares | 70,573,609 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.54 |
|---|---|
| PEG | -12.64 |
| Price to Sales | - |
| Price to Book Ratio | 3.85 |
| Enterprise Value to Revenue | 9480.01 |
| Enterprise Value to EBIT | -10 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data